The Sheng Jing Hospital was founded by Dugald Christie, a Scottish missionary doctor in 1883. It was the base on which the Mukden Medical College was formed, also by Christie, in 1912.

During the past decade, Shengjing Hospital of China Medical University conducted 227 clinical trials. In the 10-year time frame, 227 clinical trials started and 21 clinical trials were completed, i.e. on average, 9.3% percent of trials that started reached the finish line to date. In the past 5 years, 155 clinical trials started and 16 clinical trials were completed. i.e. 10.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shengjing Hospital of China Medical University" #1 sponsor was "Shengjing Hospital" with 62 trials, followed by "Janssen Research & Development, LLC" with 19 trials sponsored, "Nanfang Hospital of Southern Medical University" with 11 trials sponsored, "Hoffmann-La Roche" with 9 trials sponsored and "Jiangsu HengRui Medicine Co., Ltd." with 9 trials sponsored. Other sponsors include 155 different institutions and companies that sponsored additional 109 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shengjing Hospital of China Medical University" #1 collaborator was "Shengjing Hospital" with 14 trials as a collaborator, "Eli Lilly and Company" with 6 trials as a collaborator, "Major Science and Technology Special Project of China Eleventh Five-year" with 4 trials as a collaborator, "Peking University First Hospital" with 4 trials as a collaborator and "Sichuan Provincial People's Hospital" with 4 trials as a collaborator. Other collaborators include 309 different institutions and companies that were collaborators in the rest 263 trials.

According to Clinical.Site data, the most researched conditions in "Shengjing Hospital of China Medical University" are "Breast Cancer" (15 trials), "Hepatitis B, Chronic" (9 trials), "General Anesthesia" (8 trials), "Heart Failure" (6 trials) and "Postoperative Sleep Quality" (6 trials). Many other conditions were trialed in "Shengjing Hospital of China Medical University" in a lesser frequency.

Most popular intervention types in "Shengjing Hospital of China Medical University" are "Drug" (187 trials), "Other" (25 trials), "Device" (19 trials), "Procedure" (19 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "placebo" (7 trials), "Dexamethasone" (5 trials), "Amivantamab" (4 trials) and "Carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Shengjing Hospital of China Medical University" are 220 trials for "All" genders, 47 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 134 active trials in "Shengjing Hospital of China Medical University". 8 are not yet recruiting, 98 are recruiting, 23 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 83 completed trials in Shengjing Hospital of China Medical University, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Shengjing Hospital of China Medical University, 13 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 97 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 34 trials, and there were also 43 trials that are defined as “Not Applicable".

Shengjing Hospital of China Medical University has several departments that took part in Clinical trials: "The first hospital of China Medical University/Oncology Department" - 2 trials